{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:33:15Z","timestamp":1790188395113,"version":"4.1.0"},"reference-count":63,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Azoles have long been regarded as an ideal scaffold for the development of numerous\ninnovative therapeutic agents as well as other incredibly adaptable and beneficial chemicals with\nprospective uses in a variety of fields, including materials, energetics (explosophores), and catalysis\n(azole organocatalytic arbitration). Azoles exhibit promising pharmacological activities, including\nantimicrobial, antidiabetic, antiviral, antidepressant, antihistaminic, antitumor, antioxidant, antiallergic,\nantihelmintic, and antihypertensive activity. According to a database analysis of U.S. FDAapproved\nmedications, 59% of specific medications are connected to small molecules that have\nheterocycles having nitrogen atoms. The azole moiety has impressive electron abundance. Azoles\npromptly attach to various receptors as well as enzymes in the physiological environment via distinct\nspecialized interactions, contributing to their anti-diabetic potential. This review encompasses\nthe recent research progress on potent azole-derived antidiabetic agents that can be used as an alternative\nfor the management of type-2 diabetes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734064289990240524055002","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T05:14:52Z","timestamp":1717650892000},"page":"855-875","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting Diabetes with Azole-derived Medicinal Agents"],"prefix":"10.2174","volume":"20","author":[{"given":"Anuradha","family":"Mehra","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University,\nJalandhar-Delhi G.T. Road (NH-1), Phagwara (Punjab) 144411, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","year":"2009","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care  2009,32(1),S62-S67","journal-title":"Diabetes Care"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","volume":"10","author":"Banday M.Z.","year":"2020","unstructured":"Banday M.Z.; Sameer A.S.; Nissar S.; Pathophysiology of diabetes: An overview. Avicenna J Med  2020,10(4),174-188","journal-title":"Avicenna J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5897\/JPAP2013.0001","volume":"4","author":"Ozougwu O.","year":"2013","unstructured":"Ozougwu O.; Obimba K.C.; Belonwu C.D.; Unakalamba C.B.; The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol  2013,4(4),46-57","journal-title":"J Physiol Pathophysiol"},{"key":"ref=4","first-page":"17","volume":"13","author":"El Khatabi K.","year":"2023","unstructured":"El Khatabi K.; El-Mernissi R.; Hajji H.; Singh A.K.; Aziz M.; Lakhlifi T.; Kumar S.; Bouachrine M.; Identification of novel indole derivatives as potent \u03b1-amylase inhibitors for the treatment of type-II diabetes using in-silico approaches. Biointerface Res Appl Chem  2023,13(1),17","journal-title":"Biointerface Res Appl Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1573397115666190115143226","volume":"15","author":"Rajaei E.","year":"2019","unstructured":"Rajaei E.; Jalali M.T.; Shahrabi S.; Asnafi A.A.; Pezeshki S.M.S.; HLAs in autoimmune diseases: Dependable diagnostic biomarkers? Curr Rheumatol Rev  2019,15(4),269-276","journal-title":"Curr Rheumatol Rev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.2337\/diacare.21.3.C19","volume":"21","author":"K\u00fchl C.","year":"1998","unstructured":"K\u00fchl C.; Etiology and pathogenesis of gestational diabetes. Diabetes Care  1998,21(2),B19-B26","journal-title":"Diabetes Care"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"Saeedi P.","year":"2019","unstructured":"Saeedi P.; Petersohn I.; Salpea P.; Malanda B.; Karuranga S.; Unwin N.; Colagiuri S.; Guariguata L.; Motala A.A.; Ogurtsova K.; Shaw J.E.; IDF diabetes atlas committee global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract  2019,157(107843),10-16","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.autrev.2008.04.008","volume":"7","author":"Knip M.","year":"2008","unstructured":"Knip M.; Siljander H.; Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev  2008,7(7),550-557","journal-title":"Autoimmun Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","volume":"15","author":"Kahaly G.J.","year":"2016","unstructured":"Kahaly G.J.; Hansen M.P.; Type 1 diabetes associated autoimmunity. Autoimmun Rev  2016,15(7),644-648","journal-title":"Autoimmun Rev"},{"key":"ref=10","first-page":"506","volume":"19","author":"Tan K.T.","year":"1990","unstructured":"Tan K.T.; Cheah J.S.; Pathogenesis of type 1 and type 2 diabetes mellitus. Ann Acad Med Singap  1990,19(4),506-511","journal-title":"Ann Acad Med Singap"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI200524531","volume":"115","author":"Buchanan T.A.","year":"2005","unstructured":"Buchanan T.A.; Xiang A.H.; Gestational diabetes mellitus. J Clin Invest  2005,115(3),485-491","journal-title":"J Clin Invest"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0002-9378(99)70662-9","volume":"180","author":"Catalano P.M.","year":"1999","unstructured":"Catalano P.M.; Huston L.; Amini S.B.; Kalhan S.C.; Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol  1999,180(4),903-916","journal-title":"Am J Obstet Gynecol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1210\/jc.2010-0668","volume":"95","author":"Leahy J.L.","year":"2010","unstructured":"Leahy J.L.; Hirsch I.B.; Peterson K.A.; Schneider D.; Targeting \u03b2-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab  2010,95(9),4206-4216","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrm2327","volume":"9","author":"Muoio D.M.","year":"2008","unstructured":"Muoio D.M.; Newgard C.B.; Molecular and metabolic mechanisms of insulin resistance and \u03b2-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol  2008,9(3),193-205","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"105127","DOI":"10.1016\/j.bioorg.2021.105127","volume":"114","author":"Azimi F.","year":"2021","unstructured":"Azimi F.; Azizian H.; Najafi M.; Hassanzadeh F.; Sadeghi-aliabadi H.; Ghasemi J.B.; Ali Faramarzi M.; Mojtabavi S.; Larijani B.; Saghaei L.; Mahdavi M.; Design and synthesis of novel quinazolinone-pyrazole derivatives as potential \u03b1-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study. Bioorg Chem  2021,114,105127","journal-title":"Bioorg Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"113325","DOI":"10.1016\/j.ejmech.2021.113325","volume":"217","author":"Jo J.","year":"2021","unstructured":"Jo J.; Lee D.; Park Y.H.; Choi H.; Han J.; Park D.H.; Choi Y.K.; Kwak J.; Yang M.K.; Yoo J.W.; Moon H.R.; Geum D.; Kang K.S.; Yun H.; Discovery and optimization of novel 3-benzyl-N-phenyl-1H-pyrazole-5-carboxamides as bifunctional antidiabetic agents stimulating both insulin secretion and glucose uptake. Eur J Med Chem  2021,217,113325","journal-title":"Eur J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1700223","DOI":"10.1002\/ardp.201700223","volume":"351","author":"Naim M.J.","year":"2018","unstructured":"Naim M.J.; Alam O.; Alam M.J.; Shaquiquzzaman M.; Alam M.M.; Naidu V.G.M.; Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole\u2010based 2,4\u2010thiazolidinedione derivatives as PPAR\u2010\u03b3 modulators. Arch Pharm  2018,351(3-4),1700223","journal-title":"Arch Pharm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.ijbiomac.2020.10.263","volume":"166","author":"Azimi F.","year":"2021","unstructured":"Azimi F.; Ghasemi J.B.; Azizian H.; Najafi M.; Faramarzi M.A.; Saghaei L.; Sadeghi-aliabadi H.; Larijani B.; Hassanzadeh F.; Mahdavi M.; Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential \u03b1-glucosidase inhibitor: Kinetics and molecular dynamics simulation study. Int J Biol Macromol  2021,166,1082-1095","journal-title":"Int J Biol Macromol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","volume":"76","author":"Naim M.J.","year":"2018","unstructured":"Naim M.J.; Alam O.; Alam M.J.; Hassan M.Q.; Siddiqui N.; Naidu V.G.M.; Alam M.I.; Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents. Bioorg Chem  2018,76,98-112","journal-title":"Bioorg Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"103271","DOI":"10.1016\/j.bioorg.2019.103271","volume":"92","author":"Bansal G.","year":"2019","unstructured":"Bansal G.; Singh S.; Monga V.; Thanikachalam P.V.; Chawla P.; Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents. Bioorg Chem  2019,92,103271","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/jhet.3951","volume":"57","author":"Mohamed M.A.A.","year":"2020","unstructured":"Mohamed M.A.A.; Abd Allah O.A.; Bekhit A.A.; Kadry A.M.; El-Saghier A.M.M.; Synthesis and antidiabetic activity of novel triazole derivatives containing amino acids. J Heterocycl Chem  2020,57(6),2365-2378","journal-title":"J Heterocycl Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1002\/jhet.4142","volume":"57","author":"Asgari M.S.","year":"2020","unstructured":"Asgari M.S.; Tahmasebi B.; Mojtabavi S.; Faramarzi M.A.; Rahimi R.; Ranjbar P.R.; Biglar M.; Larijani B.; Rastegar H.; Mohammadi-Khanaposhtani M.; Mahdavi M.; Design, synthesis, biological evaluation, and docking study of new acridine\u20109\u2010carboxamide linked to 1,2,3\u2010triazole derivatives as antidiabetic agents targeting \u03b1\u2010glucosidase. J Heterocycl Chem  2020,57(12),4348-4357","journal-title":"J Heterocycl Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ejmech.2019.05.045","volume":"177","author":"Ye G.J.","year":"2019","unstructured":"Ye G.J.; Lan T.; Huang Z.X.; Cheng X.N.; Cai C.Y.; Ding S.M.; Xie M.L.; Wang B.; Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: \u03b1-Glucosidase inhibition and glucose uptake promotion. Eur J Med Chem  2019,177,362-373","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2016.09.067","volume":"125","author":"Wang G.","year":"2017","unstructured":"Wang G.; Peng Z.; Wang J.; Li X.; Li J.; Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential \u03b1-glucosidase inhibitors. Eur J Med Chem  2017,125,423-429","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40360-018-0266-6","volume":"19","author":"Ayeleso A.O.","year":"2018","unstructured":"Ayeleso A.O.; Joseph J.S.; Oguntibeju O.O.; Mukwevho E.; Evaluation of free radical scavenging capacity of methoxy containing-hybrids of thiosemicarbazone-triazole and their influence on glucose transport. BMC Pharmacol Toxicol  2018,19(1),84","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"129446","DOI":"10.1016\/j.molstruc.2020.129446","volume":"1224","author":"Sever B.","year":"2021","unstructured":"Sever B.; Alt\u0131ntop M.D.; Demir Y.; Pekdo\u011fan M.; Akal\u0131n \u00c7ift\u00e7i G.; Beydemir \u015e.; \u00d6zdemir A.; An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives. J Mol Struct  2021,1224,129446","journal-title":"J Mol Struct"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"105073","DOI":"10.1016\/j.bioorg.2021.105073","volume":"114","author":"Aroua L.M.","year":"2021","unstructured":"Aroua L.M.; Almuhaylan H.R.; Alminderej F.M.; Messaoudi S.; Chigurupati S.; Al-mahmoud S.; Mohammed H.A.; A facile approach synthesis of benzoylaryl benzimidazole as potential \u03b1-amylase and \u03b1-glucosidase inhibitor with antioxidant activity. Bioorg Chem  2021,114,105073","journal-title":"Bioorg Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2000090","DOI":"10.1002\/ardp.202000090","volume":"353","author":"Deswal L.","year":"2020","unstructured":"Deswal L.; Verma V.; Kumar D.; Kaushik C.P.; Kumar A.; Deswal Y.; Punia S.; Synthesis and antidiabetic evaluation of benzimidazole\u2010tethered 1,2,3\u2010triazoles. Arch Pharm  2020,353(9),2000090","journal-title":"Arch Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bioorg.2016.12.009","volume":"70","author":"Zawawi N.K.N.A.","year":"2017","unstructured":"Zawawi N.K.N.A.; Taha M.; Ahmat N.; Ismail N.H.; Wadood A.; Rahim F.; Synthesis, molecular docking studies of hybrid benzimidazole as \u03b1 -glucosidase inhibitor. Bioorg Chem  2017,70,184-191","journal-title":"Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejmech.2018.03.011","volume":"150","author":"Adegboye A.A.","year":"2018","unstructured":"Adegboye A.A.; Khan K.M.; Salar U.; Aboaba S.A.; Kanwal ; Chigurupati S.; Fatima I.; Taha M.; Wadood A.; Mohammad J.I.; Khan H.; Perveen S.; 2-Aryl benzimidazoles: Synthesis, In vitro \u03b1-amylase inhibitory activity, and molecular docking study. Eur J Med Chem  2018,150,248-260","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ddr.21807","volume":"82","author":"Ahmad M.U.","year":"2021","unstructured":"Ahmad M.U.; Rafiq M.; Zahra B.; Islam M.; Ashraf M.; al-Rashida M.; Khan A.; Hussain J.; Shafiq Z.; Al-Harrasi A.; Synthesis of benzimidazole based hydrazones as non\u2010sugar based \u03b1\u2010glucosidase inhibitors: Structure activity relation and molecular docking. Drug Dev Res  2021,82(7),1033-1043","journal-title":"Drug Dev Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.bmcl.2019.07.035","volume":"29","author":"Babkov D.A.","year":"2019","unstructured":"Babkov D.A.; Zhukowskaya O.N.; Borisov A.V.; Babkova V.A.; Sokolova E.V.; Brigadirova A.A.; Litvinov R.A.; Kolodina A.A.; Morkovnik A.S.; Sochnev V.S.; Borodkin G.S.; Spasov A.A.; Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators. Bioorg Med Chem Lett  2019,29(17),2443-2447","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.bioorg.2021.105046","volume":"114","author":"Gani R.S.","year":"2021","unstructured":"Gani R.S.; Kudva A.K.; Timanagouda K.; Raghuveer ; Mujawar S.B.H.; Joshi S.D.; Raghu S.V.; Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors. Bioorg Chem  2021,114,105046","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bioorg.2018.08.010","volume":"81","author":"Nazir M.","year":"2018","unstructured":"Nazir M.; Abbasi M.A.; Aziz-ur-Rehman ; Siddiqui S.Z.; Khan K.M.; Kanwal ; Salar U.; Shahid M.; Ashraf M.; Arif Lodhi M.; Ali Khan F.; New indole based hybrid oxadiazole scaffolds with N-substituted acetamides: As potent anti-diabetic agents. Bioorg Chem  2018,81,253-263","journal-title":"Bioorg Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bioorg.2017.12.037","volume":"77","author":"Bhutani R.","year":"2018","unstructured":"Bhutani R.; Pathak D.P.; Kapoor G.; Husain A.; Kant R.; Iqbal M.A.; Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model. Bioorg Chem  2018,77,6-15","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"103867","DOI":"10.1016\/j.bioorg.2020.103867","volume":"100","author":"Kaur P.","year":"2020","unstructured":"Kaur P.; Bhat Z.R.; Bhat S.; Kumar R.; Kumar R.; Tikoo K.; Gupta J.; Khurana N.; Kaur J.; Khatik G.L.; Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha\/gamma dual agonist. Bioorg Chem  2020,100,103867","journal-title":"Bioorg Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.bmcl.2019.07.004","volume":"29","author":"Harada K.","year":"2019","unstructured":"Harada K.; Mizukami J.; Watanabe T.; Mori G.; Ubukata M.; Suwa K.; Fukuda S.; Negoro T.; Sato M.; Inaba T.; Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Bioorg Med Chem Lett  2019,29(16),2100-2106","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bioorg.2017.07.009","volume":"74","author":"Taha M.","year":"2017","unstructured":"Taha M.; Rahim F.; Imran S.; Ismail N.H.; Ullah H.; Selvaraj M.; Javid M.T.; Salar U.; Ali M.; Khan K.M.; Synthesis, \u03b1 -glucosidase inhibitory activity and in silico study of trisindole hybrid scaffold with oxadiazole ring: As potential leads for the management of type-II diabetes mellitus. Bioorg Chem  2017,74,30-40","journal-title":"Bioorg Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejmech.2018.12.069","volume":"164","author":"Li Z.","year":"2019","unstructured":"Li Z.; Chen Y.; Zhou Z.; Deng L.; Xu Y.; Hu L.; Liu B.; Zhang L.; Discovery of first-in-class thiazole-based dual FFA1\/PPAR\u03b4 agonists as potential anti-diabetic agents. Eur J Med Chem  2019,164,352-365","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.compbiolchem.2018.02.018","volume":"73","author":"Charaya N.","year":"2018","unstructured":"Charaya N.; Pandita D.; Grewal A.S.; Lather V.; Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators. Comput Biol Chem  2018,73,221-229","journal-title":"Comput Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"104110","DOI":"10.1016\/j.bioorg.2020.104110","volume":"102","author":"Sever B.","year":"2020","unstructured":"Sever B.; Alt\u0131ntop M.D.; Demir Y.; Akal\u0131n \u00c7ift\u00e7i G.; Beydemir \u015e.; \u00d6zdemir A.; Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds. Bioorg Chem  2020,102,104110","journal-title":"Bioorg Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejmech.2016.02.040","volume":"113","author":"Li Z.","year":"2016","unstructured":"Li Z.; Qiu Q.; Xu X.; Wang X.; Jiao L.; Su X.; Pan M.; Huang W.; Qian H.; Design, synthesis and Structure\u2013activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Eur J Med Chem  2016,113,246-257","journal-title":"Eur J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"83438","DOI":"10.1039\/C6RA15948F","volume":"6","author":"Gao H.D.","year":"2016","unstructured":"Gao H.D.; Liu P.; Yang Y.; Gao F.; Sulfonamide-1,3,5-triazine\u2013thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4. RSC Advances  2016,6(86),83438-83447","journal-title":"RSC Advances"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"105210","DOI":"10.1016\/j.bioorg.2021.105210","volume":"115","author":"Gummidi L.","year":"2021","unstructured":"Gummidi L.; Kerru N.; Ebenezer O.; Awolade P.; Sanni O.; Islam M.S.; Singh P.; Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through \u03b1-glucosidase and \u03b1-amylase inhibition. Bioorg Chem  2021,115,105210","journal-title":"Bioorg Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"104638","DOI":"10.1016\/j.bioorg.2021.104638","volume":"108","author":"Alomari M.","year":"2021","unstructured":"Alomari M.; Taha M.; Rahim F.; Selvaraj M.; Iqbal N.; Chigurupati S.; Hussain S.; Uddin N.; Almandil N.B.; Nawaz M.; Khalid Farooq R.; Khan K.M.; Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of \u03b1-glucosidase enzyme along with in silico study. Bioorg Chem  2021,108,104638","journal-title":"Bioorg Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/13880209.2019.1642363","volume":"57","author":"Hichri F.","year":"2019","unstructured":"Hichri F.; Omri A.; Hossan A.S.M.; Ben Jannet H.; Alpha-glucosidase and amylase inhibitory effects of Eruca vesicaria subsp. longirostris essential oils: synthesis of new 1,2,4-triazole-thiol derivatives and 1,3,4-thiadiazole with potential inhibitory activity. Pharm Biol  2019,57(1),564-570","journal-title":"Pharm Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/jhet.3941","volume":"57","author":"Vaishnav Y.","year":"2020","unstructured":"Vaishnav Y.; Dewangan D.; Verma S.; Mishra A.; Thakur A.S.; Kashyap P.; Verma S.K.; PPAR gamma targeted molecular docking and synthesis of some new amide and urea substituted 1, 3, 4\u2010thiadiazole derivative as antidiabetic compound. J Heterocycl Chem  2020,57(5),2213-2224","journal-title":"J Heterocycl Chem"},{"key":"ref=48","first-page":"152","volume":"11","author":"Hameed S.A.","year":"2020","unstructured":"Hameed S.A.; Varkey J.; Jayasekhar P.; In Silico design, synthesis and in vitro antidiabetic activity of novel 5-furyl-1, 3, 4-thiadiazolimines. Int J Pharm Sci Res  2020,11(06),152-159","journal-title":"Int J Pharm Sci Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.cdc.2021.100648","volume":"32","author":"Selvarasu S.","year":"2021","unstructured":"Selvarasu S.; Srinivasan P.; Mannathusamy G.; Maria Susai B.; Synthesis, characterization, in silico molecular modeling, anti-diabetic and antimicrobial screening of novel 1-aryl-N-tosyl-1H-tetrazole-5-carboxamide derivatives. Chem DatColl  2021,32,100648","journal-title":"Chem DatColl"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"103221","DOI":"10.1016\/j.bioorg.2019.103221","volume":"92","author":"Maheshwari N.","year":"2019","unstructured":"Maheshwari N.; Karthikeyan C.; Bhadada S.V.; Verma A.K.; Sahi C.; Moorthy N.S.H.N.; Trivedi P.; Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors. Bioorg Chem  2019,92,103221","journal-title":"Bioorg Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ddr.21606","volume":"81","author":"Kattimani P.P.","year":"2020","unstructured":"Kattimani P.P.; Somagond S.M.; Bayannavar P.K.; Kamble R.R.; Bijjaragi S.C.; Hunnur R.K.; Joshi S.D.; Novel 5\u2010(1\u2010aryl\u20101 H \u2010pyrazol\u20103\u2010yl)\u20101 H \u2010tetrazoles as glycogen phosphorylase inhibitors: An in vivo antihyperglycemic activity study. Drug Dev Res  2020,81(1),70-84","journal-title":"Drug Dev Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4172\/pharmaceutical-sciences.1000125","volume":"78","author":"Kaushik N.","year":"2016","unstructured":"Kaushik N.; Kumar N.; Kumar A.; Synthesis, antioxidant and antidiabetic activity of 1-[(5-substituted phenyl)-4, 5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole. Indian J Pharm Sci  2016,78(3),352-359","journal-title":"Indian J Pharm Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bmcl.2017.12.022","volume":"28","author":"Huang H.","year":"2018","unstructured":"Huang H.; Winters M.P.; Meegalla S.K.; Arnoult E.; Paul Lee S.; Zhao S.; Martin T.; Rady B.; Liu J.; Towers M.; Otieno M.; Xu F.; Lim H.K.; Silva J.; Pocai A.; Player M.R.; Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists. Bioorg Med Chem Lett  2018,28(3),429-436","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bioorg.2018.10.025","volume":"83","author":"Bhutani R.","year":"2019","unstructured":"Bhutani R.; Pathak D.P.; Kapoor G.; Husain A.; Iqbal M.A.; Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment. Bioorg Chem  2019,83,6-19","journal-title":"Bioorg Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1039\/C5NJ03589A","volume":"40","author":"Kharbanda C.","year":"2016","unstructured":"Kharbanda C.; Alam M.S.; Hamid H.; Javed K.; Bano S.; Ali Y.; Dhulap A.; Alam P.; Pasha M.A.Q.; Novel benzothiazole based sulfonylureas\/sulfonylthioureas: Design, synthesis and evaluation of their antidiabetic potential. New J Chem  2016,40(8),6777-6786","journal-title":"New J Chem"},{"key":"ref=56","first-page":"3250","volume":"20","author":"Kumar S.","year":"2020","unstructured":"Kumar S.; Mittal A.; Pathak A.; Sahu S.K.; Biological assessments of substituted benzothiazole derivatives in streptozocin induced diabetes rats. Plant Arch  2020,20,3250-3253","journal-title":"Plant Arch"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/molecules22091555","volume":"22","author":"Gong Z.","year":"2017","unstructured":"Gong Z.; Peng Y.; Qiu J.; Cao A.; Wang G.; Peng Z.; Synthesis, in vitro \u03b1-glucosidase inhibitory activity and molecular docking studies of novel benzothiazole-triazole derivatives. Molecules  2017,22(9),1555","journal-title":"Molecules"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bioorg.2018.02.013","volume":"78","author":"Shah S.","year":"2018","unstructured":"Shah S.; Arshia ; Javaid K.; Zafar H.; Mohammed Khan K.; Khalil R.; Ul-Haq Z.; Perveen S.; Iqbal Choudhary M.; Synthesis, and In vitro and in silico \u03b1-glucosidase inhibitory studies of 5-chloro-2-aryl benzo [d] thiazoles. Bioorg Chem  2018,78,269-279","journal-title":"Bioorg Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bmcl.2019.01.012","volume":"29","author":"Adib M.","year":"2019","unstructured":"Adib M.; Peytam F.; Shourgeshty R.; Mohammadi-Khanaposhtani M.; Jahani M.; Imanparast S.; Faramarzi M.A.; Larijani B.; Moghadamnia A.A.; Esfahani E.N.; Bandarian F.; Mahdavi M.; Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro \u03b1-glucosidase inhibition, kinetic, and in silico studies. Bioorg Med Chem Lett  2019,29(5),713-718","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11030-020-10072-8","volume":"25","author":"Asgari M.S.","year":"2021","unstructured":"Asgari M.S.; Mohammadi-Khanaposhtani M.; Sharafi Z.; Faramarzi M.A.; Rastegar H.; Nasli Esfahani E.; Bandarian F.; Ranjbar Rashidi P.; Rahimi R.; Biglar M.; Mahdavi M.; Larijani B.; Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro \u03b1-glucosidase inhibition, kinetic and docking studies. Mol Divers  2021,25(2),877-888","journal-title":"Mol Divers"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1080\/10406638.2021.1939069","volume":"42","author":"Lohitha N.","year":"2022","unstructured":"Lohitha N.; Vijayakumar V.; Imidazole appended novel phenoxyquinolines as new inhibitors of \u03b1-amylase and \u03b1-glucosidase evidenced with molecular docking studies. Polycycl Aromat Compd  2022,42(8),5521-5533","journal-title":"Polycycl Aromat Compd"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"115196","DOI":"10.1016\/j.bmc.2019.115196","volume":"28","author":"Kyriakis E.","year":"2020","unstructured":"Kyriakis E.; Karra A.G.; Papaioannou O.; Solovou T.; Skamnaki V.T.; Liggri P.G.V.; Zographos S.E.; Szennyes E.; Bokor \u00c9.; Kun S.; Psarra A.M.G.; Soms\u00e1k L.; Leonidas D.D.; The architecture of hydrogen and sulfur \u03c3-hole interactions explain differences in the inhibitory potency of C-\u03b2-d-glucopyranosyl thiazoles, imidazoles and an N-\u03b2-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design. Bioorg Med Chem  2020,28(1),115196","journal-title":"Bioorg Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1016\/j.bmcl.2016.10.057","volume":"26","author":"Wang G.","year":"2016","unstructured":"Wang G.; Peng Z.; Wang J.; Li J.; Li X.; Synthesis and biological evaluation of novel 2,4,5-triarylimidazole\u20131,2,3-triazole derivatives via click chemistry as \u03b1-glucosidase inhibitors. Bioorg Med Chem Lett  2016,26(23),5719-5723","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064289990240524055002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230680\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064289990240524055002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T08:57:37Z","timestamp":1733561857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230680\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064289990240524055002","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}